"Combined novel ultra-diluted bioactive formulation enhances Sodium Stibogluconate efficacy via T cell-mediated cytokine modulation in experimental visceral leishmaniasis".
BACKGROUND Visceral leishmaniasis (VL), caused by Leishmania donovani, is a life-threatening neglected tropical disease that continues to pose a major public health challenge in endemic regions. Although sodium stibogluconate (SSG) has been widely used for VL treatment, its therapeutic efficacy has been undermined by i...